Journals / Turkish Journal of Medical Sciences / 1998 / Cilt: 28 - Sayı: 3

Clinical Utility of Lymphocyte Cross-Matching after Renal Transplantation

Pages
265–267
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

On the other hand, of 88 patients, whose LCM remained negative, only 8 lost their grafts (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:One of the most important obstacles in renal transplantation is the rejection phenomenon.
📊
Key Findings & Data:LCM was positive in 7 patients and 5 lost their grafts.
💡
Conclusion & Impact:On the other hand, of 88 patients, whose LCM remained negative, only 8 lost their grafts (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Lymphocyte Cross-match (LCM) · Renal transplantation Graft survival · DTT

Abstract

One of the most important obstacles in renal transplantation is the rejection phenomenon. In spite of the developments in medical technology and immunology, early diagnosis of rejection and specific immunosuppression of the immune attack against the graft have not yet been totally accomplished. Lymphocyte cross-matching (LCM), a test to detect the presence of preformed antibodies in the donor against the recipient, is a practical and cheap method and is performed at almost all renal transplantation centers before transplantation. In this study, we searched for the relation between the posttransplant LCM status and graft survival. LCM was positive in 7 patients and 5 lost their grafts. On the other hand, of 88 patients, whose LCM remained negative, only 8 lost their grafts (p

Özet

One of the most important obstacles in renal transplantation is the rejection phenomenon. In spite of the developments in medical technology and immunology, early diagnosis of rejection and specific immunosuppression of the immune attack against the graft have not yet been totally accomplished. Lymphocyte cross-matching (LCM), a test to detect the presence of preformed antibodies in the donor against the recipient, is a practical and cheap method and is performed at almost all renal transplantation centers before transplantation. In this study, we searched for the relation between the posttransplant LCM status and graft survival. LCM was positive in 7 patients and 5 lost their grafts. On the other hand, of 88 patients, whose LCM remained negative, only 8 lost their grafts (p

🔖

Cite This Article

YEĞİN, O., SÜLEYMANLAR, G., OYGÜR, N., COŞKUN, M., SAVAŞ, A., KEÇECİOĞLU, N., KARPUZOĞLU, T. (2022). Clinical Utility of Lymphocyte Cross-Matching after Renal Transplantation. Turkish Journal of Medical Sciences, Cilt: 28 - Sayı: 3, 265–267. https://ajindex.com/articles/612679

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...